When it comes to childhood cancer, we’re ready.

We exist to help children with cancer, from day one and every day after.

Tell me more
;

When it comes to childhood cancer, we’re ready.

We exist to help children with cancer, from day one and every day after.

Tell me more
;

Ready to make an impact

We are working hard to bring novel targeted therapies to children with brain cancer and potentially others who can benefit.
Show me more

Recent press releases

View all

05/25/2023

Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Read More

05/01/2023

Day One Reports First Quarter 2023 Financial Results and Corporate Progress

Read More

04/26/2023

Day One Announces Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Read More

Join our team as we work together to develop medicines that make a difference for patients.

See open jobs